MediWound (MDWD) Assets Average (2016 - 2026)
MediWound (MDWD) posted Assets Average of $75.9 million for Q2 2026, down 8.65% on a QoQ basis from $83.1 million in Q1 2026, and up 11.65% year-over-year from $68.0 million in Q2 2025.
Analysis
MediWound (MDWD) Assets Average (2016 - 2026) Analysis & Trends
MediWound has reported Assets Average for 11 years, with the latest figure at $75.9 million in Q2 2026.
- On a quarterly basis, Assets Average rose 11.65% year-over-year to $75.9 million in Q2 2026; TTM through Jun 2026 was $75.9 million, a 11.65% increase from a year earlier, with the FY2025 full-year figure at $79.9 million, up 14.14% from the prior year.
- Assets Average was $75.9 million for Q2 2026 at MediWound, down from $83.1 million in the prior quarter.
- The five-year high for Assets Average was $90.3 million in Q4 2025, with the low at $23.1 million in Q1 2022.
- Average Assets Average over 5 years is $61.3 million, with a median of $66.3 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Assets Average declined 24.11% in 2022, then soared 180.23% in 2023.
- Over 5 years, Assets Average stood at $39.3 million in 2022, then soared by 69.81% to $66.7 million in 2023, then grew by 11.05% to $74.1 million in 2024, then gained by 21.89% to $90.3 million in 2025, then retreated by 15.95% to $75.9 million in 2026.
- The last three Assets Average figures came in at $75.9 million (Q2 2026), $83.1 million (Q1 2026), and $90.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.51 Bn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 75.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.93 Mn |
| Mar 31, 2026 | 83.12 Mn |
| Dec 31, 2025 | 90.34 Mn |
| Sep 30, 2025 | 80.71 Mn |
| Jun 30, 2025 | 68.01 Mn |
| Mar 31, 2025 | 71.26 Mn |
| Dec 31, 2024 | 74.12 Mn |
| Sep 30, 2024 | 66.02 Mn |
| Jun 30, 2024 | 59.84 Mn |
| Mar 31, 2024 | 64.42 Mn |
| Dec 31, 2023 | 66.74 Mn |
| Sep 30, 2023 | 65.69 Mn |
| Jun 30, 2023 | 66.52 Mn |
| Mar 31, 2023 | 59.34 Mn |
| Dec 31, 2022 | 39.30 Mn |
| Sep 30, 2022 | 24.85 Mn |
| Jun 30, 2022 | 23.74 Mn |
| Mar 31, 2022 | 23.06 Mn |
| Dec 31, 2021 | 21.46 Mn |
| Sep 30, 2021 | 24.69 Mn |